(Q42990589)

English

Stability of hepatitis C virus (HCV) RNA levels among interferon-naïve HIV/HCV-coinfected individuals treated with combination antiretroviral therapy

scientific article published on 27 March 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Stability of hepatitis C virus (HCV) RNA levels among interferon-naïve HIV/HCV-coinfected individuals treated with combination antiretroviral therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Hepatitis C virus

1 reference

based on heuristic

inferred from title

object named as

D Grint

1

0 references

Vicente Soriano

object named as

V Soriano

4

0 references

6

object named as

B Knysz

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

5

object named as

O Kirk

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

11

object named as

A Mocroft

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

author name string

L Peters

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

J Reekie

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

O Suetnov

7

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

A Lazzarin

8

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

B Ledergerber

9

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

J K Rockstroh

10

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

EuroSIDA in EuroCoord (European Coordinating Committee for the Integration of Ongoing Coordination Actions Related to Clinical and Epidemiological HIV Research)

12

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

publication date

27 March 2013

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

370-378

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12033

21 January 2018

Viral hepatitis and HIV co-infection

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12033

21 January 2018

Hepatitis C virus is related to progressive liver disease in human immunodeficiency virus-positive hemophiliacs and should be treated as an opportunistic infection

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12033

21 January 2018

Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12033

21 January 2018

Survival in patients with HIV infection and viral hepatitis B or C: a cohort study

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12033

21 January 2018

Impact of hepatitis C virus coinfection on response to highly active antiretroviral therapy and outcome in HIV-infected individuals: a nationwide cohort study

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12033

21 January 2018

Hepatitis C and HIV infection: biological, clinical, and therapeutic implications

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12033

21 January 2018

Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12033

21 January 2018

Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12033

21 January 2018

The prognostic value of a single hepatitis C virus RNA load measurement taken early after human immunodeficiency virus seroconversion

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12033

21 January 2018

Determinants of the quantity of hepatitis C virus RNA.

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12033

21 January 2018

Stability of HCV-RNA level and its lack of correlation with disease severity in asymptomatic chronic hepatitis C virus carriers

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12033

21 January 2018

Decline in the AIDS and death rates in the EuroSIDA study: an observational study

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12033

21 January 2018

Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12033

21 January 2018

Is sexual contact a major mode of hepatitis C virus transmission?

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12033

21 January 2018

Serum HCV RNA levels assessed by quantitative NASBA: stability of viral load over time, and lack of correlation with liver disease. The Trent HCV Study Group

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12033

21 January 2018

Meta-analysis: IL28B polymorphisms predict sustained viral response in HCV patients treated with pegylated interferon-α and ribavirin

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12033

21 January 2018

Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12033

21 January 2018

Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12033

21 January 2018

Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIV.

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12033

21 January 2018

Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in co-infected subjects

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12033

21 January 2018

Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12033

21 January 2018

Review of the effect of highly active antiretroviral therapy on hepatitis C virus (HCV) RNA levels in human immunodeficiency virus and HCV coinfection.

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12033

21 January 2018

Clearance of hepatitis C virus in HIV-infected patients with multiple chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12033

21 January 2018

Identifiers

10.1111/HIV.12033

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42990589&oldid=1975924802"